CHINARES PHARMA (03320): China Resources Sanjiu Medical & Pharmaceutical's net profit for the first 9 months was approximately RMB 2.601 billion, a year-on-year decrease of 10.28%
China Resources Pharmaceutical (03320) announced the results of China Resources Sanjiu for the first 9 months of 2026, with total operating revenue of approximately RMB 21.41 billion, a year-on-year decrease of 2.62%; net profit of approximately RMB 2.601 billion, a year-on-year decrease of 10.28%.
CHINARES PHARMA (03320) announced the results of China Resources Sanjiu Medical & Pharmaceutical for the first 9 months of 2026, with total operating revenue of approximately RMB 21.41 billion, a year-on-year decrease of 2.62%; net profit of approximately RMB 2.601 billion, a year-on-year decrease of 10.28%.
Related Articles
K W NELSON GP (08411) will distribute a special dividend of HK$0.02 per share on December 8.
YUM CHINA (09987) repurchased 24,000 shares on October 22 for HK$8.238 million.
XIAO NOODLES (02408) repurchased 107,000 shares on October 23 for approximately HK$405,400.
K W NELSON GP (08411) will distribute a special dividend of HK$0.02 per share on December 8.
YUM CHINA (09987) repurchased 24,000 shares on October 22 for HK$8.238 million.
XIAO NOODLES (02408) repurchased 107,000 shares on October 23 for approximately HK$405,400.
